Drawing for CODEXIS PROTEIN ENGINEERING EXPERTS

USPTO serial 87706494

CODEXIS PROTEIN ENGINEERING EXPERTS

Reviewed by CopyMark Law Group

Reg. 6075394Status 700Renewal
Filing date
Status date
Registration date
Jun 9, 2020
Examiner
FICKES, JERI J
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with CODEXIS PROTEIN ENGINEERING EXPERTS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,097*

Plus Government fees of $1,275

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

GABRIELLE S. ROTH

GABRIELLE S. ROTH SUGHRUE MION, PLLC2000 PENNSYLVANIA AVENUE, N.W.WASHINGTON, DC 20006UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001chemicals for use in research in industry and science; chemicals for use in the manufacture of products for commercial applications pertaining to chemistry, pharmaceuticals, and medicine; chemicals and biochemicals for in vitro scientific and research use; chemicals and biochemicals for use in the manufacture of products for commercial use; enzymes used to produce chemicals for research; enzymes used to produce chemicals for use in the manufacture of products for commercial applications pertaining to chemistry, pharmaceuticals, and medicine; chemicals and biochemicals for use in the synthesis of pharmaceuticals and chemicals; chemical and biochemical catalysts for use in pharmaceutical and chemical productionACTIVE—
040biomanufacturing in the nature of directed evolution services, namely, recombination of genes, proteins and enzymes for the benefit of others to produce novel gene sequences, proteins and enzymes for use in scientific and medical research, and industrial and commercial applications in the fields of chemistry, pharmaceuticals, biotherapeutics, and food and beverages; manufacture of chemicals for othersACTIVEOct 28, 2017
042biochemistry research and product development for others, namely, custom design and development of highly optimized proteins and enzymes for use in the fields of scientific and medical research, industry and commercial applications; chemical research services; scientific research services; research, product development, and related process development services for others in the fields of chemistry, pharmaceuticals, biotherapeutics, and food and beveragesACTIVEOct 28, 2017

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 9, 2025REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jun 9, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 6, 2020SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
May 5, 2020CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Apr 30, 2020SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Apr 30, 2020AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Apr 15, 2020IUAFUSE AMENDMENT FILED—
Apr 15, 2020EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Dec 6, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 4, 2019EX2GSOU EXTENSION 2 GRANTED—
Dec 4, 2019EXT2SOU EXTENSION 2 FILED—
Dec 4, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 17, 2019TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 31, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 29, 2019EX1GSOU EXTENSION 1 GRANTED—
May 29, 2019EXT1SOU EXTENSION 1 FILED—
May 29, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 4, 2018NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 9, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 9, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 19, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 22, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 22, 2018XAECEXAMINER'S AMENDMENT ENTERED—
Aug 22, 2018GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Aug 22, 2018GNEAEXAMINERS AMENDMENT E-MAILED—
Aug 22, 2018CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 23, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 23, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 23, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 16, 2018DOCKASSIGNED TO EXAMINER—
Dec 13, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 7, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance